Overactive bladder drug linked to depression

By Australian Hospital + Healthcare Bulletin Staff
Thursday, 06 April, 2017

A recent international study published in The Journal of Clinical Pharmacology found that women who received antimuscarinics as part of treatment for overactive bladder were 38% more likely to be diagnosed with depressive disorder within the next 3 years than those who did not receive antimuscarinics.

“This population-based retrospective cohort study found that use of antimuscarinics was associated with subsequent depressive disorder in women with overactive bladder,” said Li-Ting Kao, senior author of study.

Although antimuscarinics can significantly depress bladder contractions and improve symptoms by blocking muscarinic receptors, studies have found that several unwanted side effects frequently occur when patients with an overactive bladder receive the drugs.

The cognitive effects (including memory loss) of antimuscarinic drugs in elderly patients are well established. One theory for the increased rate of side effects in elderly people is the increased blood-brain barrier permeability that can occur with advanced age and certain comorbidities may facilitate antimuscarinic access to the central nervous system.

Related News

Rheumatoid arthritis risk for some occupations

Assistant nursing, and other occupations, may have increased risk of contracting rheumatoid...

Communications gap between doctors and home-care nurses creating issues

Patients discharged from hospital, particularly the elderly, are becoming caught in a web of poor...

Debunking nursing clichés will attract school leavers

Stereotypes portraying nurses as sexual objects or merely doctors' helpers must be combatted...

  • All content Copyright © 2017 Westwick-Farrow Pty Ltd